▶ 調査レポート

筋骨格障害治療薬の世界市場:市場規模・現状・予測

• 英文タイトル:Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。筋骨格障害治療薬の世界市場:市場規模・現状・予測 / Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2019-2025 / QYR9ST03691資料のイメージです。• レポートコード:QYR9ST03691
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、筋骨格障害治療薬の世界市場について調査・分析し、筋骨格障害治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(生物製剤、小分子、その他)、用途別(変形性関節症、骨粗鬆症、乾癬性関節炎、強直性脊椎炎、線維筋痛症、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の筋骨格障害治療薬市場動向
・主要企業別マーケットシェア
・筋骨格障害治療薬の種類別市場規模2014-2019
(生物製剤、小分子、その他)
・筋骨格障害治療薬の用途別市場規模2014-2019
(変形性関節症、骨粗鬆症、乾癬性関節炎、強直性脊椎炎、線維筋痛症、その他)
・筋骨格障害治療薬の北米市場:主要企業・種類別/用途別市場規模
・筋骨格障害治療薬のヨーロッパ市場:主要企業・種類別/用途別市場規模
・筋骨格障害治療薬の中国市場:主要企業・種類別/用途別市場規模
・筋骨格障害治療薬の日本国内市場:主要企業・種類別/用途別市場規模
・筋骨格障害治療薬の東南アジア市場:主要企業・種類別/用途別市場規模
・筋骨格障害治療薬のインド市場:主要企業・種類別/用途別市場規模
・筋骨格障害治療薬の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Pfizer、AbbVie、Johnson & Johnson、Sanofi、Merck、Novartis、Eli Lilly、AstraZeneca、Boehringer Ingelheim、F. Hoffmann-La Roche、Amgen、Takeda Pharmaceutical、Daiichi Sankyo、LG Life Sciences、Astellas、Samsung Bioepis、Zosano Pharma、Taisho Pharmaceutical、3SBio)
・筋骨格障害治療薬の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

Musculoskeletal disorders are the group of pain disorders or injuries that affect the body’s joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range of causes, but usually occur depending on the age, lifestyle, and occupation of an individual. Symptoms usually range from recurrent pain, stiffness, and swellings. X-rays and other medical imaging procedures may diagnose the condition. The treatment mainly depends on the severity of the condition. Apart from the drugs, physical therapy, and occupational therapy are also used to manage the condition.MSDs mostly occur because of the over-exhaustion of weak muscles, ligaments, or tendons. Also, vigorous vocational activities can lead to musculoskeletal pain. Uncured MSDs can result in chronic disruption of the mundane and vocational tasks of the patient. Some of the major therapeutics to treat MSDs include corticosteroids, biologics, parathyroid hormone, selective estrogen receptor modulators, protein therapy, synthetic bone graft, demineralized bone matrix, composite grafts, and BMPS, orthobiologics.
In 2018, the global Musculoskeletal Disorders Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Musculoskeletal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Musculoskeletal Disorders Therapeutics development in United States, Europe and China.

The key players covered in this study
Pfizer
AbbVie
Johnson & Johnson
Sanofi
Merck
Novartis
Eli Lilly
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
Amgen
Takeda Pharmaceutical
Daiichi Sankyo
LG Life Sciences
Astellas
Samsung Bioepis
Zosano Pharma
Taisho Pharmaceutical
3SBio

Market segment by Type, the product can be split into
Biologics
Small Molecules
Other

Market segment by Application, split into
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Musculoskeletal Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Musculoskeletal Disorders Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Musculoskeletal Disorders Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Biologics
1.4.3 Small Molecules
1.4.4 Other
1.5 Market by Application
1.5.1 Global Musculoskeletal Disorders Therapeutics Market Share by Application (2014-2025)
1.5.2 Osteoarthritis
1.5.3 Osteoporosis
1.5.4 Psoriatic Arthritis
1.5.5 Ankylosing Spondylitis
1.5.6 Fibromyalgia
1.5.7 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Musculoskeletal Disorders Therapeutics Market Size
2.2 Musculoskeletal Disorders Therapeutics Growth Trends by Regions
2.2.1 Musculoskeletal Disorders Therapeutics Market Size by Regions (2014-2025)
2.2.2 Musculoskeletal Disorders Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Musculoskeletal Disorders Therapeutics Market Size by Manufacturers
3.1.1 Global Musculoskeletal Disorders Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Musculoskeletal Disorders Therapeutics Key Players Head office and Area Served
3.3 Key Players Musculoskeletal Disorders Therapeutics Product/Solution/Service
3.4 Date of Enter into Musculoskeletal Disorders Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Musculoskeletal Disorders Therapeutics Market Size by Type (2014-2019)
4.2 Global Musculoskeletal Disorders Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
5.2 Musculoskeletal Disorders Therapeutics Key Players in United States
5.3 United States Musculoskeletal Disorders Therapeutics Market Size by Type
5.4 United States Musculoskeletal Disorders Therapeutics Market Size by Application

6 Europe
6.1 Europe Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
6.2 Musculoskeletal Disorders Therapeutics Key Players in Europe
6.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Type
6.4 Europe Musculoskeletal Disorders Therapeutics Market Size by Application

7 China
7.1 China Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
7.2 Musculoskeletal Disorders Therapeutics Key Players in China
7.3 China Musculoskeletal Disorders Therapeutics Market Size by Type
7.4 China Musculoskeletal Disorders Therapeutics Market Size by Application

8 Japan
8.1 Japan Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
8.2 Musculoskeletal Disorders Therapeutics Key Players in Japan
8.3 Japan Musculoskeletal Disorders Therapeutics Market Size by Type
8.4 Japan Musculoskeletal Disorders Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
9.2 Musculoskeletal Disorders Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Type
9.4 Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Application

10 India
10.1 India Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
10.2 Musculoskeletal Disorders Therapeutics Key Players in India
10.3 India Musculoskeletal Disorders Therapeutics Market Size by Type
10.4 India Musculoskeletal Disorders Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Musculoskeletal Disorders Therapeutics Market Size (2014-2019)
11.2 Musculoskeletal Disorders Therapeutics Key Players in Central & South America
11.3 Central & South America Musculoskeletal Disorders Therapeutics Market Size by Type
11.4 Central & South America Musculoskeletal Disorders Therapeutics Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Musculoskeletal Disorders Therapeutics Introduction
12.1.4 Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 AbbVie
12.2.1 AbbVie Company Details
12.2.2 Company Description and Business Overview
12.2.3 Musculoskeletal Disorders Therapeutics Introduction
12.2.4 AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.2.5 AbbVie Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Musculoskeletal Disorders Therapeutics Introduction
12.3.4 Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.3.5 Johnson & Johnson Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Musculoskeletal Disorders Therapeutics Introduction
12.4.4 Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Musculoskeletal Disorders Therapeutics Introduction
12.5.4 Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Musculoskeletal Disorders Therapeutics Introduction
12.6.4 Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Musculoskeletal Disorders Therapeutics Introduction
12.7.4 Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.7.5 Eli Lilly Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Company Details
12.8.2 Company Description and Business Overview
12.8.3 Musculoskeletal Disorders Therapeutics Introduction
12.8.4 AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.8.5 AstraZeneca Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Company Details
12.9.2 Company Description and Business Overview
12.9.3 Musculoskeletal Disorders Therapeutics Introduction
12.9.4 Boehringer Ingelheim Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.9.5 Boehringer Ingelheim Recent Development
12.10 F. Hoffmann-La Roche
12.10.1 F. Hoffmann-La Roche Company Details
12.10.2 Company Description and Business Overview
12.10.3 Musculoskeletal Disorders Therapeutics Introduction
12.10.4 F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)
12.10.5 F. Hoffmann-La Roche Recent Development
12.11 Amgen
12.12 Takeda Pharmaceutical
12.13 Daiichi Sankyo
12.14 LG Life Sciences
12.15 Astellas
12.16 Samsung Bioepis
12.17 Zosano Pharma
12.18 Taisho Pharmaceutical
12.19 3SBio

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Musculoskeletal Disorders Therapeutics Key Market Segments
Table Key Players Musculoskeletal Disorders Therapeutics Covered
Table Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Musculoskeletal Disorders Therapeutics Market Size Market Share by Type 2014-2025
Figure Biologics Figures
Table Key Players of Biologics
Figure Small Molecules Figures
Table Key Players of Small Molecules
Figure Other Figures
Table Key Players of Other
Table Global Musculoskeletal Disorders Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Osteoarthritis Case Studies
Figure Osteoporosis Case Studies
Figure Psoriatic Arthritis Case Studies
Figure Ankylosing Spondylitis Case Studies
Figure Fibromyalgia Case Studies
Figure Other Case Studies
Figure Musculoskeletal Disorders Therapeutics Report Years Considered
Table Global Musculoskeletal Disorders Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Musculoskeletal Disorders Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Musculoskeletal Disorders Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Musculoskeletal Disorders Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Musculoskeletal Disorders Therapeutics Market Share by Regions 2014-2019
Figure Global Musculoskeletal Disorders Therapeutics Market Share by Regions 2014-2019
Figure Global Musculoskeletal Disorders Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Musculoskeletal Disorders Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Musculoskeletal Disorders Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Musculoskeletal Disorders Therapeutics Market Share by Manufacturers in 2018
Table Global Musculoskeletal Disorders Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Musculoskeletal Disorders Therapeutics Product/Solution/Service
Table Date of Enter into Musculoskeletal Disorders Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Musculoskeletal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Musculoskeletal Disorders Therapeutics Market Size Share by Type (2014-2019)
Figure Global Musculoskeletal Disorders Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Musculoskeletal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Musculoskeletal Disorders Therapeutics Market Size Share by Application (2014-2019)
Figure Global Musculoskeletal Disorders Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Application in 2018
Figure United States Musculoskeletal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Musculoskeletal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Musculoskeletal Disorders Therapeutics Market Share (2018-2019)
Table United States Musculoskeletal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Musculoskeletal Disorders Therapeutics Market Share by Type (2014-2019)
Table United States Musculoskeletal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Musculoskeletal Disorders Therapeutics Market Share by Application (2014-2019)
Figure Europe Musculoskeletal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Musculoskeletal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Musculoskeletal Disorders Therapeutics Market Share (2018-2019)
Table Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Musculoskeletal Disorders Therapeutics Market Share by Type (2014-2019)
Table Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Musculoskeletal Disorders Therapeutics Market Share by Application (2014-2019)
Figure China Musculoskeletal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Musculoskeletal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Musculoskeletal Disorders Therapeutics Market Share (2018-2019)
Table China Musculoskeletal Disorders Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Musculoskeletal Disorders Therapeutics Market Share by Type (2014-2019)
Table China Musculoskeletal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Musculoskeletal Disorders Therapeutics Market Share by Application (2014-2019)
Figure Japan Musculoskeletal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Musculoskeletal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Musculoskeletal Disorders Therapeutics Market Share (2018-2019)
Table Japan Musculoskeletal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Musculoskeletal Disorders Therapeutics Market Share by Type (2014-2019)
Table Japan Musculoskeletal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Musculoskeletal Disorders Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Musculoskeletal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Musculoskeletal Disorders Therapeutics Market Share (2018-2019)
Table Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Musculoskeletal Disorders Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Musculoskeletal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Musculoskeletal Disorders Therapeutics Market Share by Application (2014-2019)
Figure India Musculoskeletal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Musculoskeletal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Musculoskeletal Disorders Therapeutics Market Share (2018-2019)
Table India Musculoskeletal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Musculoskeletal Disorders Therapeutics Market Share by Type (2014-2019)
Table India Musculoskeletal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Musculoskeletal Disorders Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Musculoskeletal Disorders Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Musculoskeletal Disorders Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Musculoskeletal Disorders Therapeutics Market Share (2018-2019)
Table Central & South America Musculoskeletal Disorders Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Musculoskeletal Disorders Therapeutics Market Share by Type (2014-2019)
Table Central & South America Musculoskeletal Disorders Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Musculoskeletal Disorders Therapeutics Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2014-2019)
Table AbbVie Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table Merck Company Details
Table Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2014-2019)
Table Eli Lilly Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2014-2019)
Table AstraZeneca Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Amgen Company Details
Table Takeda Pharmaceutical Company Details
Table Daiichi Sankyo Company Details
Table LG Life Sciences Company Details
Table Astellas Company Details
Table Samsung Bioepis Company Details
Table Zosano Pharma Company Details
Table Taisho Pharmaceutical Company Details
Table 3SBio Company Details
Table Global Musculoskeletal Disorders Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Musculoskeletal Disorders Therapeutics Market Size Share by Regions in 2025
Figure United States Musculoskeletal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Musculoskeletal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Musculoskeletal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Musculoskeletal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Musculoskeletal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Musculoskeletal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Musculoskeletal Disorders Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Musculoskeletal Disorders Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Musculoskeletal Disorders Therapeutics Market Size by Product (2019-2025)
Figure Global Musculoskeletal Disorders Therapeutics Market Size by Product in 2025
Table Global Musculoskeletal Disorders Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Musculoskeletal Disorders Therapeutics Market Size by Application (2019-2025)
Figure Global Musculoskeletal Disorders Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources